028300.KQ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 02:30):

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea...

Stats
Today's Volume	1.68M
Average Volume	3.64M
Market Cap	14 310.40B
EPS	KRW0 ( 2024-02-15 )
Next earnings date	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW148.95 (0.14%)

Volume Correlation

Long: -0.10 (neutral)

Short: -0.98 (very strong negative)

Signal:(22.242) Possible Trading Opportunity Present (swing)

HLB Co., Ltd. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

HLB Co., Ltd. Correlation - Currency/Commodity

0.21
( neutral )

0.16
( neutral )

-0.45
( neutral )

0.27
( neutral )

0.67
( moderate )

-0.29
( neutral )

HLB Co., Ltd. Financials

Annual	2023
Revenue:	KRW42.90B
Gross Profit:	KRW-6.01B (-14.01 %)
EPS:	KRW-1 559.61

Q4	2023
Revenue:	KRW9.02B
Gross Profit:	KRW-1.87B (-20.73 %)
EPS:	KRW-915.42

Q3	2023
Revenue:	KRW9.73B
Gross Profit:	KRW-1.24B (-12.70 %)
EPS:	KRW-164.00

Q2	2023
Revenue:	KRW4.33B
Gross Profit:	KRW-5.63B (-130.03 %)
EPS:	KRW-228.57

Financial Reports:

No articles found.

HLB Co., Ltd.

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.